This trial is testing whether a more abbreviated course of proton therapy is just as effective for low and intermediate risk prostate cancer patients as the current standard of care, which is a longer course of proton therapy.
- Prostate Cancer
1 Primary · 2 Secondary · Reporting Duration: 2 years & 5 years
2 Treatment Groups
Low Risk Prostate Cancer
1 of 2
Intermediate Risk Prostate Cancer
1 of 2
235 Total Participants · 2 Treatment Groups
Primary Treatment: Low Risk Prostate Cancer · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · Male Participants · 18 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are involved in this research endeavor?
"Affirmative. According to the details hosted on clinicaltrials.gov, this medical study is actively enrolling participants; having first been posted on January 1st 2014 and last updated April 3rd 2019. It requires 235 individuals from two different sites for completion." - Anonymous Online Contributor
Are there any remaining patient openings for this experiment?
"The details on clinicaltrials.gov denote that this experiment is currently seeking participants with its inception date being 1/1/2014 and latest adjustment occurring 4/3/2019." - Anonymous Online Contributor